Harvey E. Behrend

Array ( [id] => 4409516 [patent_doc_number] => 06239182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Method for preventing sexually transmitted diseases' [patent_app_type] => 1 [patent_app_number] => 9/252417 [patent_app_country] => US [patent_app_date] => 1999-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14082 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239182.pdf [firstpage_image] =>[orig_patent_app_number] => 252417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381289 [patent_doc_number] => 20020119950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'USEOF ANABOLIC AGENTS ANTI-CATABOLIC AGENTS AND ANTIOXIDANT AGENTS FOR PROTECTION TREATMENT AND REPAIR OF CONNECTIVE TISSUES IN HUMANS AND ANIMALS' [patent_app_type] => new [patent_app_number] => 09/249335 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7490 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119950.pdf [firstpage_image] =>[orig_patent_app_number] => 09249335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4208842 [patent_doc_number] => 06028115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Method for preventing sexually transmitted diseases' [patent_app_type] => 1 [patent_app_number] => 9/243035 [patent_app_country] => US [patent_app_date] => 1999-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13972 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028115.pdf [firstpage_image] =>[orig_patent_app_number] => 243035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4251945 [patent_doc_number] => 06207653 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus' [patent_app_type] => 1 [patent_app_number] => 9/230021 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1903 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207653.pdf [firstpage_image] =>[orig_patent_app_number] => 230021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4368724 [patent_doc_number] => 06274611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Methods and compositions for inhibition of viral replication' [patent_app_type] => 1 [patent_app_number] => 9/232158 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7977 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274611.pdf [firstpage_image] =>[orig_patent_app_number] => 232158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1441219 [patent_doc_number] => 06335339 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Triazine antiviral compounds' [patent_app_type] => B1 [patent_app_number] => 09/229703 [patent_app_country] => US [patent_app_date] => 1999-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 93 [patent_figures_cnt] => 265 [patent_no_of_words] => 13715 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 382 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335339.pdf [firstpage_image] =>[orig_patent_app_number] => 09229703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190445 [patent_doc_number] => 06153615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis' [patent_app_type] => 1 [patent_app_number] => 9/228977 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 8596 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153615.pdf [firstpage_image] =>[orig_patent_app_number] => 228977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4313031 [patent_doc_number] => 06316495 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Method for inhibition of retroviral replication' [patent_app_type] => 1 [patent_app_number] => 9/227392 [patent_app_country] => US [patent_app_date] => 1999-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6079 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316495.pdf [firstpage_image] =>[orig_patent_app_number] => 227392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128115 [patent_doc_number] => 06127422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Anti-viral method' [patent_app_type] => 1 [patent_app_number] => 9/214536 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31170 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 818 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127422.pdf [firstpage_image] =>[orig_patent_app_number] => 214536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4287983 [patent_doc_number] => 06268336 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Pharmaceutical composition for treatment of hepatic diseases' [patent_app_type] => 1 [patent_app_number] => 9/202614 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2886 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268336.pdf [firstpage_image] =>[orig_patent_app_number] => 202614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352978 [patent_doc_number] => 06291471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Use of apomorphine for the treatment of organic erectile dysfunction in males' [patent_app_type] => 1 [patent_app_number] => 9/213567 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4150 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291471.pdf [firstpage_image] =>[orig_patent_app_number] => 213567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295370 [patent_doc_number] => 06180681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => '2-cyclopenten-1-one as an inducer of HSP70' [patent_app_type] => 1 [patent_app_number] => 9/202553 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2254 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180681.pdf [firstpage_image] =>[orig_patent_app_number] => 202553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174261 [patent_doc_number] => 06083911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Arenavirus receptor and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/208707 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9209 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083911.pdf [firstpage_image] =>[orig_patent_app_number] => 208707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4104028 [patent_doc_number] => 06051579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection' [patent_app_type] => 1 [patent_app_number] => 9/209666 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1488 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051579.pdf [firstpage_image] =>[orig_patent_app_number] => 209666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421430 [patent_doc_number] => 06225289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Methods and compositions for preserving adenoviral vectors' [patent_app_type] => 1 [patent_app_number] => 9/208666 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2874 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225289.pdf [firstpage_image] =>[orig_patent_app_number] => 208666 [rel_patent_id] =>[rel_patent_doc_number] =>)